Key result
Heart failure linked to a ~7% reduction in health-related quality of life.
Why the study?
Heart failure-specific PROMs have limited generalizability beyond clinical cohorts, and the CDC Healthy Days Survey remains underutilized in HF populations to track HRQoL at the population level.
Does heart failure reduce health-related quality of life compared to individuals without heart failure in a nationally representative US population?
Observational (n=33,021)
Does heart failure reduce health-related quality of life compared to individuals without heart failure in a nationally representative US population?
Mean Difference: -0.055 (95% CI -0.071–-0.04)
Absolute Event Rate: 0.785% vs 0.84%
Heart failure is associated with a clinically significant 6.55% reduction in health-related quality of life compared to the general population, highlighting the utility of the CDC's Healthy Days Survey for population-level monitoring.
Highlights substantial HRQoL burden in heart failure; extends US population data but leaves open causal and interventional implications.
BACKGROUND: Individuals with heart failure (HF) experience various symptoms making both diagnosis and disease burden estimates challenging. While HF-specific patient-reported outcome measures (PROMs) are widely used, their focus on clinical cohorts limits their generalizability. Preference-based measures like the EQ-5D enable standardized health-related quality of life (HRQoL) comparisons across conditions, supporting resource allocation decisions. The CDC's Healthy Days (HD) Survey-a simple two-question tool that can be mapped to the EQ-5D-offers a broader approach to tracking HRQoL but remains underutilized in HF populations. METHODS: Using a nationally representative U.S. sample, we mapped HD Survey responses to EQ-5D utility scores to compare HRQoL between individuals with and without HF and examined changes in HRQoL over time. We assessed whether HD-derived scores align with HF-specific utility measures to support population-level health monitoring. RESULTS: Individuals with HF report significantly more physically unhealthy days (8.46 vs. 3.42) and mentally unhealthy days (5.42 vs. 3.86) compared to those without HF. HF respondents are, on average, 20 years older than those without HF, consistent with HF's prevalence in older adults. The likelihood of an HF diagnosis is similar for men and women but higher among non-Hispanic whites and blacks than Hispanics and other races. Those with HF are more likely to have health insurance. Adjusting for age, sex, race, and insurance, mean EQ-5D utility scores for individuals with and without HF are 0.785 (95% CI: 0.714-0.825) and 0.840 (95% CI: 0.827-0.851), respectively. Utility scores for HF patients remain significantly lower than those without HF up to 10 years post-diagnosis. CONCLUSION: HF reduces HRQoL by 6.55%, surpassing the clinically significant threshold of a 1-2% decrement. These findings highlight the potential of the HD Survey to inform public health monitoring and underscore the need for tailored interventions to address HRQoL deficits in HF populations.
No takes yet. Share an insight, caveat, or question.
Alva et al. (2025) conducted an observational in Heart failure (n=33,021). Heart failure vs. No heart failure was evaluated on Adjusted mean EQ-5D utility score (MD -0.055, 95% CI -0.071 to -0.040). Heart failure reduces health-related quality of life by 6.55%, with adjusted mean EQ-5D utility scores of 0.785 for individuals with heart failure compared to 0.840 for those without.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: